Biolife, a wholly owned subsidiary of Merit Medical

Biolife, LLC is a medical device company based in Sarasota, Florida, and is a wholly-owned subsidiary of Merit Medical Systems, Inc. The company focuses on creating innovative healthcare and first-aid solutions aimed at improving patient quality of life. Biolife's mission is to enhance patient care and outcomes, with a vision to reduce pain and suffering. The company manufactures patented hemostatic devices under the brands StatSeal and WoundSeal. StatSeal is designed for healthcare professionals and includes a powder and disc products that control bleeding from indwelling catheters and procedural sites. WoundSeal is targeted at consumers and is a powder that stops bleeding from wounds by forming a protective scab. Biolife's products are clinically validated and address a significant market opportunity, generating approximately $15 million in revenue for the fiscal year ending December 31, 2024. Following its acquisition, Merit Medical plans to expand Biolife's reach in various medical fields.